A limited number of HLA epitopes are recognized from HLA class I- specific antibodies detected in the serum of sensitized patients

Human Immunology

Volumn 61, Issue 7, 2000, Pages 705-710

  Papassavas, Andreas C ^a   Iniotaki Theodoraki, Aliki ^a   Boletis, John ^b   Douramani, Panagiota ^a   Kostakis, Alkiviadis ^b   Stavropoulos Giokas, Catherine ^a  

^a IASO GENERAL HOSPITAL   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

Anti CREG antibodies; Crossreactive group epitopes; Private and public HLA epitopes; Sensitized patients

Indexed keywords

ANTIBODY; EPITOPE; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA B35 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ALLOIMMUNITY; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT SURVIVAL; HLA MATCHING; HUMAN; LYMPHOCYTOTOXICITY; MALE; PRIORITY JOURNAL; SERUM; TRANSPLANTATION;

ANTIBODIES; ANTIBODY SPECIFICITY; BLOOD GROUP INCOMPATIBILITY; EPITOPES, B-LYMPHOCYTE; FEMALE; FOLLOW-UP STUDIES; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 0033923223     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(00)00125-7     Document Type: Article

References (27)

1. Duquesnoy R.J., White L.T., Fierst J.W., Vanek M., Banner B.F., Iwaki Y., Starzl T.E. Multiscreen serum analysis of highly sensitized renal dialysis patients for antibodies toward public and private class I HLA determinants. Implications for computer-predicted acceptable and unacceptable donor mismatches in kidney transplantation. Transplantation. 50:1990;427.
2. Rodey G.E., Fuller T.C. Public epitopes and the antigenic structure of HLA molecules. CRC Ctic Rev Immunol. 7:1987;229.
3. Fuller A.A., Trevithich J.A., Rodey G.E., Parham P., Fuller T.C. Topographic map of the HLA-A2 CREG epitopes using human alloantibody probes. Hum Immunol. 28:1990;284.
4. Fuller A.A., Rodey G.E., Parham P., Fuller T.C. Epitope map of the HLA-B7 CREG using affinity-purified human alloantibody probes. Hum Immunol. 28:1990;306.
5. Starzl T.E., Eliasziw M., Gjertson D., Terasaki P.I., Fung J.J., Trucco M., Martell J., McMichael J., Scantlebury V., Shapiro R., Donner A. HLA and cross-reactive antigen group matching for cadaver kidney allocation. Transplantation. 64:1997;983.
6. Benichou G., Tam R.C., Soares L.R.P., Fedoseyeva E. Indirect T-cell allorecognition perspectives for peptide-based therapy in transplantation . Immunol Today. 18:1997;67.
7. Johnson A.H., Rossen R.D., Butler W.T. Detection of alloantibodies using a sensitive antiglobulin microcytotoxicity test identification of low levels of pre-formed antibodies in accelerated allograft rejection . Tissue Antigens. 2:1972;215.
8. Iwaki Y., Lau M., Terasaki P.I. Successful transplants across T warm-positive crosshatches due to IgM antibodies. Clin Transplant. 2:1988;81.
9. Zachary A.A., Griffin J., Lucas D.P., Hart J.M., Leffell M.S. Evaluation of HLA antibodies with PRA-STAT. Transplantation. 60:1995;1600.
10. Bjorkman P, Parham P. Class I MHC molecules. Annu Rev Biochem 59:253, 1990.
11. Duquesnoy R.J., Marrari M. Determination of HLA-A,B residue mismatch acceptability for kidneys transplanted into highly sensitized patients. A report of a collaborative study conducted during the 12th International Histocompatibility Workshop. Transplantation. 63:1997;1743.
12. Papassavas AC, Iniotaki-Theodoraki A, Boletis J, Kostakis A, Stavropoulos-Giokas C: Epitope analysis of HLA class I donor specific antibodies in sensitized renal transplant recipients. Transplantation (in press).
13. Fernández-Fresnedo G., Pastor J.M., Ruiz J.C., Cotorruelo J.G., Setién M.A., López-Hoyos M., Arias M. Differences in anti-CREG antibody formation between transplanted and nontransplanted renal patients. Transplantation. 67:1999;1188.
14. Rodey G.E., Neylan J.F., Whelchel J.D., Revels K.W., Bray R.A. Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant pecipients. Hum Immunol. 39:1994;272.
15. Rodey G.E., Revels K., Fuller T.C. Epitope specificity of HLA class I alloantibodies. II. Stability of cross-reactive group antibody over extended time periods. Transplantation. 63:1997;885.
16. DeFranco A.L. Structure and function of the B cell antigen receptor. Annu Rev Cell Biol. 9:1993;377.
17. Steele D.J.R., Laufer T.M., Smiley S.T., Ando Y., Grusby M.J., Glimcher L.H., Auchincloss H. Two levels of help for B cell alloantibody production. J Exp Med. 183:1996;699.
18. Suciu-Foca N., Liu P.E., Harris E.F., Reed E.F., Cohen D.J., Benstein J.A., Benvenisty A.I., Mancini D., Michler R.E., Rose E.A., Reemtsma K., Hardy M.A. Indirect recognition of native HLA alloantigens and B-cell help. Transplant Proc. 27:1995;455.
19. Liu Z., Colovai A.I., Tugulea S., Reed E.F., Fisher P.E., Mancini D., Rose E.A., Cortesini R., Michler R.E., Suciu-Foca N. Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest. 98:1996;1150.
20. Benichou G., Fedoseyeva E.V. The contribution of peptides to T cell allorecognition and allograft rejection. Int Rev Immunol. 13:1996;231.
21. Segers A., De Smet W., Gradl G. Only a limited set of HLA epitopes is associated with organ graft loss. Transplant Proc. 31:1999;721.
22. Fuller T.C., Fuller A. The humoral immune response against an HLA class I allodeterminant correlates with the HLA-DR phenotype of the responder. Transplantation. 68:1999;173.
23. Ciubotariu R., Liu Z., Colovai A.I., Ho E., Itescu S., Ravalli S., Hardy M.A., Cortesini R., Rose E.A., Suciu-Foca N. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest. 101:1998;398.
24. Benichou G., Malloy K.M., Tam R.C., Heeger P.S., Fedoseyeva E.V. The presentation of self and allogeneic MHC peptides to T lymphocytes. Hum Immunol. 59:1998;540.
25. Inman B., Halloran B., Melk A., Ramassar V., Halloran P.F. Microchimerism in sensitized renal patients. Transplantation. 67:1999;1381.
26. McKenna R.M., Lee K.R., Cough J.C., Jeffery J.R., Grimm P.C., Rush D.N., Nickerson P. Matching for private or public HLA epitopes reduces acute rejection episodes and improves two-year renal allograft function. Transplantation. 66:1998;38.
27. Opelz G. Ninth international histocompatibility workshop renal transplantation study. Albert D.E., Mayr W., Baur M. Histocompatibility Testing 1984. 1984;Springer Verlag, Berlin.